$VERU
Veru Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Miami, FL
VERU chart
What traders are saying about $VERU
Latest postsVeru Inc. news
- Veru executive to present obesity drug data at industry conference
Investing.com ·
- Veru to present new data on enobosarm's benefits for older obese patients using GLP-1 RA at ObesityWeek 2026
Pluang ·
- Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026
Yahoo Finance ·
- Veru to Present New Results on Effects of Enobosarm on
GlobeNewswire ·
- VERU Nov 2026 0.500 call (VERU261113C00000500) stock price, news, quote and history
Yahoo Finance Singapore ·
- VERU Nov 2026 0.500 call (VERU261113C00000500) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Veru Q4 2026 Earnings Date and Estimates
MarketBeat ·
- Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
Yahoo Finance ·
- Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
Yahoo Finance ·
- Veru (VERU) Q3 2026 Earnings Call Transcript
fool.com ·
- Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Yahoo Finance ·
- Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
Yahoo Finance ·
Veru Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $16.9M | $16.3M | $39.4M |
| Net income | -$22.7M | -$37.8M | -$93.2M | -$84.0M |
| Diluted EPS | – | – | $-1.10 | $-1.05 |
| Total assets (year end) | $47.6M | $39.8M | $80.6M | $101.3M |
| Cash and equivalents (year end) | $33.0M | $26.6M | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Veru Inc.
- Ticker
- VERU (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Miami, FL
- Incorporated in
- WI
- Fiscal year end
- September 30
- SEC CIK
- 863894
- Former names
- FEMALE HEALTH CO
Frequently asked questions
What exchange is Veru Inc. listed on?
Veru Inc. trades on the Nasdaq under the ticker symbol VERU.
What industry is Veru Inc. in?
Veru Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Veru Inc. headquartered?
Veru Inc.'s business address on file with the SEC is in Miami, FL.
When does Veru Inc.'s fiscal year end?
Veru Inc.'s fiscal year ends on September 30.
How much revenue did Veru Inc. report?
Veru Inc. reported $16.9M in revenue for calendar year 2024, according to its SEC filings.